WHO Model Formulary 2008Mark C. Stuart, Maria Kouimtzi, World Health Organization, Suzanne R. Hill Since its first publication in 2002, the WHO Model Formulary has become an indispensable source of independent information on essential medicines for pharmaceutical policy-makers and prescribers worldwide. The Model Formulary is the authoritative guide on how to make effective use of the medicines on the WHO Model List of Essential Medicines, so improving patient safety, and limiting unnecessary medical spending. For each medicine the Model Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions. The new edition, WHO Model Formulary 2008, details changes made to the WHO Model List of Essential Medicines in 2007, with updated therapeutic information on existing medicines reflecting new clinical knowledge. |
Contents
| 1 | |
| 15 | |
| 30 | |
| 47 | |
| 55 | |
| 67 | |
| 80 | |
| 214 | |
| 353 | |
| 392 | |
| 425 | |
| 432 | |
| 443 | |
| 452 | |
| 454 | |
| 473 | |
| 219 | |
| 241 | |
| 246 | |
| 256 | |
| 262 | |
| 294 | |
| 313 | |
| 320 | |
| 326 | |
| 335 | |
Common terms and phrases
Accelerated metabolism acid acute administration ADULT and CHILD Adverse effects anaemia anaphylaxis Antagonism of hypotensive anticoagulant arrhythmias artemether breastfeeding breastfeeding Appendix Carbamazepine chronic ciclosporin Clomipramine concentration possibly Contraindications convulsions corticosteroid Dexamethasone diarrhoea digoxin diuretic divided doses drugs effect Antagonism effect Enhanced hypotensive effect Increased risk elderly Enhanced hypotensive effect estrogens Fluphenazine Furosemide gastrointestinal headache hepatic impairment Appendix Hydrochlorothiazide hydrocortisone hypersensitivity reactions hypertension hypoglycaemic effect hypokalaemia hypotensive effect Enhanced immunization increased plasma concentration infant interactions intramuscular injection intravenous intravenous infusion intravenous injection introductory note isoniazid Lopinavir lumefantrine medicines mg daily mg/kg daily micrograms Model List monitor mouth nausea neonatal nephrotoxicity Nifedipine oedema oral pain patients phenytoin possibly increased possibly reduced Precautions prednisolone pregnancy Appendix prophylaxis rash reduce dose Reduced absorption renal impairment Appendix Rifampicin risk of nephrotoxicity ritonavir saquinavir severe single dose sodium symptoms syndrome Tablet therapy toxicity treatment trimester twice daily ulceration vaccine Verapamil vomiting Warfarin